What is Starr Life Sciences?
Starr Life Sciences is recognized globally for its advanced life science products tailored for small animal research. The company's comprehensive portfolio includes state-of-the-art pulse oximetry devices, telemetry systems, and activity monitoring equipment. These critical tools are instrumental in laboratories worldwide, facilitating breakthroughs in life science research. Products like the MouseOx Plus and VitalView E-Mitter are not only clinically validated but also frequently cited in leading scientific publications, highlighting their reliability and impact. Starr Life Sciences is dedicated to empowering animal researchers with high-quality, dependable solutions for precise monitoring of small laboratory animal health and behavior.
How much funding has Starr Life Sciences raised?
Starr Life Sciences has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Starr Life Sciences
PPP
Public-Private Partnership
What's next for Starr Life Sciences?
With a substantial $150K in overall funding and a recent strategic investment, Starr Life Sciences is well-positioned for its next phase of expansion. The company's focus on innovative monitoring equipment for small animal research suggests a strategic direction towards enhancing the precision and scope of preclinical studies. This capital infusion is likely to fuel further product development, market penetration, and potentially strategic acquisitions within the life sciences instrumentation sector. The company's commitment to supporting scientific advancement through reliable technology indicates a continued emphasis on research and development, aiming to solidify its leadership in the global market.
See full Starr Life Sciences company page
